Literature DB >> 35606621

Diabetic Peripheral Neuropathy.

Johan Røikjer1,2,3, Niels Ejskjaer4,5,6.   

Abstract

Diabetic painless and painful peripheral neuropathy remains the most frequent complication of diabetes mellitus, but the pathophysiology remains undescribed, there are no robust clinical endpoints and no efficient treatment exists. This hampers good clinical practice, fruitful clinical research and successful pharmacological trials, necessary for the development of early detection, prevention and treatment. This chapter supplies an update on background and treatment of diabetic peripheral neuropathy. Goals and perspectives for future clinical and scientific approaches are also described.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Diabetes; Neuropathy; Painful; Peripheral; Treatment

Mesh:

Year:  2022        PMID: 35606621     DOI: 10.1007/164_2022_585

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  54 in total

Review 1.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

Authors:  J W Baynes; S R Thorpe
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

Review 2.  The global burden of diabetic foot disease.

Authors:  Andrew J M Boulton; Loretta Vileikyte; Gunnel Ragnarson-Tennvall; Jan Apelqvist
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

Review 3.  Diabetic Foot Ulcers and Their Recurrence.

Authors:  David G Armstrong; Andrew J M Boulton; Sicco A Bus
Journal:  N Engl J Med       Date:  2017-06-15       Impact factor: 91.245

4.  Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats.

Authors:  Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurophysiol       Date:  2002-06       Impact factor: 2.714

5.  The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.

Authors:  Dyveke T Demant; Karen Lund; Jan Vollert; Christoph Maier; Märtha Segerdahl; Nanna B Finnerup; Troels S Jensen; Søren H Sindrup
Journal:  Pain       Date:  2014-08-17       Impact factor: 6.961

6.  Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons.

Authors:  J A Black; T R Cummins; C Plumpton; Y H Chen; W Hormuzdiar; J J Clare; S G Waxman
Journal:  J Neurophysiol       Date:  1999-11       Impact factor: 2.714

7.  Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not.

Authors:  David G Armstrong; Kelman Cohen; Stephane Courric; Manish Bharara; William Marston
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

8.  Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients?

Authors:  Ari Breiner; Leif Erik Lovblom; Bruce A Perkins; Vera Bril
Journal:  Diabetes Care       Date:  2014-02-26       Impact factor: 19.112

9.  Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic rats.

Authors:  K-I Cheng; H-C Wang; Y-T Chuang; C-W Chou; H-P Tu; Y-C Yu; L-L Chang; C-S Lai
Journal:  Eur J Pain       Date:  2013-07-19       Impact factor: 3.931

10.  Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy.

Authors:  Iulia Blesneac; Andreas C Themistocleous; Carl Fratter; Linus J Conrad; Juan D Ramirez; James J Cox; Solomon Tesfaye; Pallai R Shillo; Andrew S C Rice; Stephen J Tucker; David L H Bennett
Journal:  Pain       Date:  2018-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.